Statistics
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine
| Views | |
|---|---|
| Evaluating ... | 1024 |
Total Visits Per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Evaluating ... | 18 | 19 | 31 | 18 | 3 | 1 | 1 |
File Visits
| Views | |
|---|---|
| 21VmhogDXFlrE.pdf | 438 |